Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-06804103 |
Trade Name | |
Synonyms | PF06804103|PF 06804103 |
Drug Descriptions |
PF-06804103 is an antibody-drug conjugate (ADC) comprising an ERBB2 (HER2)-targeting antibody linked to Aur0101, which delivers the cytotoxic drug to ERBB2 (HER2)-expressing tumor cells, potentially resulting in decreased growth of ERBB2 (HER2)-expressing tumors (Cancer Res July 1 2018 (78) (13 Supplement) 818, PMID: 32747418, PMID: 32710210). |
DrugClasses | HER2 (ERBB2) Antibody 76 HER2 (ERBB2) Antibody-Drug Conjugate 31 |
CAS Registry Number | NA |
NCIT ID | C141420 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Letrozole + Palbociclib + PF-06804103 | Letrozole PF-06804103 Palbociclib | 0 | 1 |
PF-06804103 | PF-06804103 | 0 | 1 |